https://adisinsight.springer.com/trials/700254374?error=cookies_not_supported&code=56b5d1fd-3792-4402-b0fe-7ef856b3f01d
A Prospective, Open-label, Single-arm, Multi-Center, Phase II Trial of NOV120101 in Patients With...
This phase II trial is investigating the efficacy and tolerability of poziotinib in patients with erbB2-positive metastatic breast cancer who have failed more